减少宫颈癌手术污染的新技术
本文基于LACC试验结果,提出一种在微创根治性子宫切除术中经腹部放置阴道环扎带以封闭阴道顶端、减少宫颈口恶性肿瘤细胞腹腔污染的新技术,2例患者术后18个月以上无病生存。
要点
- LACC试验显示微创手术生存低于开腹手术且腹盆腔复发率更高。
- 新技术经腹部放置阴道环扎带封闭阴道顶端以减少肿瘤细胞腹腔污染。
- 2例患者术后18个月以上健康无病生存。
核心结论
- 经腹部放置阴道环扎带封闭阴道顶端可能减少微创宫颈癌手术中的肿瘤细胞腹腔污染。
研究设计与样本
- 本文为技术描述性研究,报告了2例采用新技术的宫颈癌患者。
主要发现
- 2例患者术后18个月以上保持健康且无病生存。
- LACC试验报告微创手术较开腹手术生存更低且腹盆腔复发率更高。
临床怎么用
- 该技术或可作为LACC试验背景下开腹手术的安全替代方案。
- 该技术旨在促进对LACC试验结果及宫颈癌手术技术的讨论和进一步研究。
局限性
- 仅报告2例患者,样本量小,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Laparoscopic Approach to Cervical Cancer (LACC) trial changed the surgical management of cervical cancer worldwide. It was a multinational phase III clinical trial that reported lower survival and higher rate of abdominopelvic recurrences in minimally invasive surgery (MIS) than those of open surgery after hysterectomy. It is possible that tumor exposure to the peritoneal cavity in the MIS arm may account for these differences. We propose a novel technique to minimize peritoneal contamination of malignant cells present at the cervical os by placing a vaginal cerclage abdominally to create a seal at the apex of the vagina during MIS radical hysterectomy. The 2 patients in this work remain healthy and disease-free more than 18 months after surgery using this novel technique. We intend this work to serve as a platform both for offering a safe alternative to the open approach supported by the LACC trial and, most importantly, for promoting discussion of the results of the LACC trial and further research on surgical techniques in the treatment of cervical cancer. MIS has repeatedly been shown to have lower rates of infection, fewer complications, and shorter hospital stays while providing oncologic care that is noninferior to open approach.
引用
- Martino MA, Bixel K, Johnson AM, et al. A Novel Technique to Minimize Contamination for Cervical Cancer Surgery Patients. J Minim Invasive Gynecol. 2020. PMID: 31931144. doi:10.1016/j.jmig.2020.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。